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Abstract 
 
Background: The incidence of cardiovascular disease is considerably disparate among 
different racial and ethnic populations. While dobutamine stress echocardiography (DSE) has 
been shown to be useful in Caucasian patients, its role among ethnic minority groups remains 
unclear. This study aimed to investigate the prognostic importance of DSE in three ethnic 
groups in the UK.  
 
Methods: DSE was performed on 6231 consecutive patients. After exclusions, 5329 patients 
formed the study (2676 [50.2%] Indian Asian, 2219 [41.6%] European white and 434 [8.1%] 
Afro-Caribbean). Study outcome measures were non-fatal cardiac events (NFCE) and all-
cause mortality.  
 
Results: There were 849 (15.9%) NFCE and 1365 (25.6%) deaths over a median follow-up 
period of 4.6 years. In total 1174 (22%) patients had inducible myocardial ischaemia during 
DSE, 859 (16.1%) had fixed wall motion abnormalities and 3645 (68.4%) patients had a 
normal study. Ethnicity did not predict events. Among the three ethnic groups, ischaemia on 
DSE was associated with 2 to 2.5 times the risk of non-fatal cardiac events and 1.2 to 1.4 
times the risk of all-cause mortality. Peak wall motion score index was the strongest 
independent predictor of non-fatal cardiac events and all-cause mortality in all groups. The C 
statistic for the prediction of NFCE and all-cause mortality were significantly higher when 
DSE parameters were added to the standard risk factors for all ethnic groups. 
 
Conclusions: DSE is a strong predictor of NFCE and all-cause mortality and provides 
predictive information beyond that provided by standard risk factors in three major racial and 
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ethnic groups. No major differences among racial and ethnic groups in the predictive value of 
DSE was detected. 
 
Key Words: Dobutamine stress echocardiography, Ethnicity, Ischaemia, Transthoracic 
echocardiography. 
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Background 
 
The UK has become more ethnically diverse with an increase in both the number and 
proportion of Afro-Caribbean and Asian minority ethnic groups. In 2011, all Afro-Caribbean 
and Asian minority groups accounted for 13% of the population in England and Wales [1]. 
The incidence of cardiovascular disease (CVD) is considerably disparate among different 
racial and ethnic populations [2]. CVD mortality is 40% higher in Indian Asians compared 
with European white groups [3] and is significantly greater among Afro-Caribbeans 
compared with European whites [2, 4]. Coronary artery disease (CAD) is the leading cause of 
premature CVD death in European whites and Asians; however, in Afro-Caribbean 
populations death from stroke is the leading cause [5]. Although conventional risk factors 
contribute to the differences in CVD, they do not adequately explain the excess risk noted in 
Afro-Caribbean and Indian Asian populations [2]. However, there may be certain ethnic 
specific CVD risk factors [3, 6]. 
 
Afro-Caribbean and Indian Asian populations are under represented in epidemiological and 
cardiovascular research trials [7]. As a result, minority ethnic groups may be at risk of 
significant disadvantage across a range of health indicators. Reporting racial information is 
important since findings from European white populations may not necessarily be 
extrapolated to other ethnic groups, given the observed differences in CVD mortality.   
 
Prior research has demonstrated a survival difference between white, black, and Hispanic 
ethnic groups undergoing exercise treadmill testing, even after adjustment for patient 
demographics, baseline electrocardiography abnormalities, CVD co-morbidities and risk 
factors, and exercise test findings [8]. Dobutamine stress echocardiography (DSE) is a widely 
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accepted and useful non-invasive test for the diagnosis, risk stratification and prognosis of 
CAD [9-12], as well as having greater specificity and sensitivity for CAD diagnosis 
compared to exercise treadmill testing. In addition, DSE has provided important prognostic 
information among different age groups [13], in men and women [14], as well as in patients 
with diabetes [15] and renal disease [16]. However, despite the available evidence, no study 
has investigated the role of DSE in predicting outcome amongst Afro-Caribbean, Caucasian 
and Indian Asian patients or determined whether myocardial ischaemia and ischaemic burden 
have the same prognostic power in these different ethnic populations. Therefore the aim of 
this prospective cohort study was to evaluate the role of DSE in the prediction of non-fatal 
cardiac events (NFCE) and all cause mortality by ethnic group. We studied a large cohort of 
consecutive patients referred for DSE and evaluated outcomes in UK Afro-Caribbean, 
European whites and Indian Asian patients.   
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Methods 
 
Study design and patients 
 
The study population consisted of 6231 consecutive patients undergoing DSE for the 
evaluation of angina pectoris or shortness of breath on exertion between June 2006 to 
September 2011 in the outpatient setting. All patients were required to provide informed 
consent before testing and the local research ethics committee approved the study. Ethnicity 
was obtained through self-report using the 2001 UK Census categorisation for classifying 
ethnicity. Exclusion criteria included mixed ethnic groups, Chinese ethnicity, patients 
referred for viability assessment only, asymptomatic patients awaiting non-cardiac surgery, 
patients with severe valve disease, and patients who did not provide signed informed consent.  
 
Before DSE, a structured history and medical record review was performed to document 
symptoms, medical history, medication use, cardiac risk factors, and previous cardiac events 
and procedures. The estimation of the pre-test probability of CAD was determined using 
previously described criteria, which included the presence and characteristics of chest pain, 
age, gender, and presence of greater than or equal to three CAD risk factors [17]. Patients 
were categorised into low, intermediate or high pre-test probability. For patients who 
underwent multiple DSE tests during this period, only the first DSE was considered in the 
analysis. 
 
Follow-up data was obtained by investigators blinded to the DSE result and information was 
collated by contacting patients or a family member, general practitioners, and reviewing 
hospital records to inquire about interim hospital admissions, outpatient diagnosis of 
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cardiovascular events, and deaths. The date of the last review or consultation was used to 
calculate the duration of follow-up through to June 2013.  
 
Dobutamine stress echocardiography 
 
All patients recruited underwent DSE. The image quality obtained was interpretable in all 
patients (1296 [24.3%] requiring contrast) and the entire cohort was used in data analysis. 
DSE was performed according to a standard protocol [18] with images acquired in the 
standard parasternal long- and short-axis and apical 2-, 3-, and 4-chamber views. The left 
ventricle (LV) was divided into a 17-segment model for qualitative analysis [19] and wall 
motion was scored on a 4-point scale (1, normal wall motion; 2, hypokinesis; 3, akinetic; and 
4, dyskinetic) as is standard [18]. In patients with resting akinetic segments a biphasic 
response was used to indicate ischaemia. LV ejection fraction was calculated using biplane 
Simpson’s technique. LV mass was derived from two-dimensional motion-mode and indexed 
to height [20]. Results were classified as a normal response with an overall increase in wall 
motion or abnormal response. An abnormal response was described as the occurrence under 
stress of hypokinesia, akinesia or dyskinesia in one or more resting normal segments and/or 
worsening of wall motion in one or more resting hypokinetic segments [21]. In this way 
patients were categorised as non-ischaemic or ischaemic. The extent and location of inducible 
ischaemia were evaluated and a wall motion score index (WMSI) was calculated, both at rest 
and during stress. Patients were further categorised with low (1-3 ischaemic LV segments) or 
high (>3 ischaemic LV segments) ischaemic burden. Non-viable myocardium was defined as 
severely dysfunctional myocardium without change during DSE [22] and referred to as fixed 
wall motion abnormalities (WMA). The territory of myocardial ischaemia was described 
according to an overlap model as previously described [23]: Left anterior descending artery 
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(LAD) – anterior wall, anteroseptum, mid and apical inferoseptum; Circumflex artery (Cx) – 
mid inferolateral wall, basal and mid lateral wall; Right coronary artery (RCA)/Cx artery – 
inferior wall, basal inferolateral wall, basal inferoseptum.   
 
End point definition 
 
The principal end-point of interest for this analysis was non-fatal cardiac events (NFCE) and 
secondarily death from any cause, with patients censored at the time of the last follow-up. A 
NFCE was defined as hospitalisation for myocardial infarction, unstable angina, and time to 
coronary revascularisation procedures, defined either as coronary artery bypass graft surgery 
or percutaneous coronary intervention. Hospitalisations were identified by means of the 
principle discharge diagnosis. For patients with multiple events, only the first event was 
considered.  
  
Data analysis 
 
Continuous variables are expressed as mean±SD and categorical variables as n (%). We used 
chi-square tests for discrete variables and one-way analysis of variance tests for continuous 
variables to test for differences in demographics, risk factors and DSE test results between 
ethnic groups and between participants with and without end point events. To describe the 
frequency of NFCE and all-cause mortality according to time since DSE, Kaplan-Meier 
cumulative event curves were constructed and compared using the log-rank test with a P 
value <0.05 considered statistically significant. The data were stratified according to A) 
ischaemic and non-ischaemic patients and B) non-ischaemic (0 segments), low ischaemic 
burden (1-3 ischaemic LV segments) and high ischaemic burden (>3 ischaemic LV 
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segments) patients for NFCE and all-cause mortality. Event rates were calculated and 
expressed as percent per year. We used Cox proportional-hazards regression to estimate 
hazard ratios and corresponding 95% confidence intervals (CI) for NFCE and all-cause 
mortality for each individual ethnic group and computed the C statistic (area under the 
receiver operator curve) as a measure of the incremental value of DSE beyond that provided 
by standard risk factors.  
 
All models were adjusted for age, gender, smoking history, diabetes, hypercholesterolemia, 
hypertension, prior myocardial infarction, prior revascularization and use of lipid lowering or 
anti-hypertensive medication. All analyses were conducted using the statistical package for 
social sciences (SPSS 21 release version of SPSS for Windows; SPSS Inc., Chicago IL, 
USA). 
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Results 
 
Study cohort 
 
Of the 6231 patients referred for DSE, 814 did not meet inclusion criteria and 88 patients 
were lost at follow-up and therefore excluded from the final analysis. The remaining 5329 
patients of which 434 (8.1%) were Afro-Caribbean, 2219 (41.6%) were European white and 
2676 (50.2%) were Indian Asian comprised the final study cohort (Figure 1). Afro-Caribbean 
and Indian Asian patients had been resident in the UK for 38±15 and 41±17, respectively, 
and European whites were born in the UK. The majority of DSE requests were due to 
suspected angina pectoris (79.7%) and the remainder were due to shortness of breath on 
exertion (20.3%). The baseline characteristics of the study cohort varied significantly among 
the three ethnic groups, as shown in Table 1. Briefly, European white patients were 
significantly older than both Afro-Caribbean and Indian Asian patients. The presence of 
hypertension, diabetes mellitus, hypercholesterolemia and previous percutaneous coronary 
intervention was significantly greater in Indian Asians compared to Afro-Caribbeans and 
European whites. Family history of cardiovascular disease and smoking history was 
significantly greater in European whites compared to Afro-Caribbeans and Indian Asians. 
The low, intermediate and high pre-test probability of CAD did not significantly (p=0.415) 
differ between ethnic groups (Table 1).  
 
Baseline atrial fibrillation was present in 82 (1.5%) patients, and 116 (2.2%) had left bundle 
branch block. Atrial fibrillation induced by DSE occurred in 27 (0.5%) patients, and non-
sustained ventricular tachycardia in 2 (0.04%) patients. None of the patients required 
intravenous beta-blocker to reverse the effects of dobutamine or treat arrhythmias. Long-term 
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cardiac medication was similar among all groups and the proportion of patients prescribed 
anti-anginal (defined as any treatment alone or in combination of beta-blockers, calcium 
antagonists, or nitrates) medication was similar between groups (Table 1). The Canadian 
Cardiovascular Society angina classification was similar between European white and Indian 
Asians, but significantly different from Afro-Caribbeans.  
 
Importantly, there were significant differences in baseline cardiac function, structure and 
geometry between ethnic groups. Afro-Caribbean patients had a significantly lower LV end 
systolic diameter and significantly greater LV end diastolic diameter (LVEDD) maximal wall 
thickness, LV mass, and LV mass index compared to European white and Indian Asian 
patients (Table 1). Indian Asian patients had a significantly smaller LVEDD compared to 
Afro-Caribbean and European white patients and a significantly greater LV ejection fraction 
compared to European white patients (Table 1). The cardiovascular risk profile was less 
favourable in patients whom went onto have a NFCE and among those who died during 
follow-up, as shown in Table 2.  
 
Clinical outcomes 
 
The mean follow-up time was 4.6±1.3 years (Afro-Caribbean: 4.6±1.2 years; European white 
4.4±1.4 years; Indian Asians 4.8±1.2 years). NFCE occurred in 849 (15.9%) patients overall 
and were noted in 12.7% (55 events) Afro-Caribbean patients, 16.4% (363 events) in 
European white patients and 16.1% (431 events) in Indian Asians. All-cause mortality 
occurred in 1365 (25.6%) of patients (24.9% in Afro-Caribbean patients, 25.4% in European 
white patients and 25.9% in Indian Asians). There were no significant differences between 
ethnic groups regarding NFCE and all-cause mortality. 
DSE IN DIFFERENT ETHNIC GROUPS 
	 12	
 
DSE was completed in all patients and the level of agreement; kappa between the two 
sonographers was 0.84. Consensus was obtained in discordant cases and 90,593 left 
ventricular segments were analysed. In total 3645 (68.4%) patients had a normal study, 1174 
(22%) patients developed a new or worsening WMA (ischaemic response) during their DSE, 
and 859 (16.1%) had fixed WMA’s. Of the patients with fixed WMA’s, 349 (40.6%) 
developed a new or worsening WMA during DSE. The territory of myocardial ischaemia did 
not significantly differ between groups (LAD, p=0.821; Cx, p=0.748; RCA, p=0.975). 
 
During the follow-up period, 958 (18%) patients (85 [19.6%] Afro-Caribbean, 366 [16.5%] 
European white, 507 [18.9%] Indian Asian) underwent coronary angiography within 29±2.2 
days of DSE. Of these patients, 561 (58.6%) had inducible ischaemia during DSE. In total, 
530 (9.9%) patients had significant (defined as ≥70% coronary lumen stenosis by visual 
determination in ≥1 coronary artery) CAD (47 [10.8%] Afro-Caribbean, 213 [9.6%] 
European white, 270 [10.1%] Indian Asian patients). The resulting sensitivity, specificity, 
positive and negative predictive values for DSE in detecting significant CAD were 93.6, 84.8, 
88.4 and 91.4%, respectively. There were no significant differences between the ethnic 
groups in the proportion of patients who underwent coronary angiography (p=0.181) or the 
proportion of patients who had significant coronary disease (p=0.781).  
 
The NFCE rate for all patients without ischaemia was 2.3% per year, increasing to 4.8% for 
patients with fixed WMA’s, 7.3% per year for those with 1-3 ischaemic segments and highest 
among those with >3 ischaemic segments (10.1% per year). Patients with any ischaemia 
during DSE had a cardiac event rate of 7.7% per year, suggesting that a positive DSE was 
associated with 90 extra NFCE per 100 person years of follow-up. 
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The all-cause mortality event rate for all patients without ischaemia was 4% per year, 
increasing to 7.9% for those with fixed WMA’s, 10.5% per year for those with 1-3 ischaemic 
segments and highest among those with >3 ischaemic segments (16% per year). Patients with 
any ischaemia during DSE had a mortality event rate of 11.2% per year, suggesting that a 
positive DSE was associated with 132 extra deaths per 100 person years of follow-up. 
 
Dobutamine stress echocardiography as a predictor of outcome 
 
Figure 2 and Figure 3 show the unadjusted Kaplan-Meier cumulative event curves for NFCE 
and all-cause mortality, respectively, dichotomized according to myocardial ischaemia (A) 
and number of ischaemic LV segments (B). The differences amongst these curves were 
significant (P<0.001) and illustrates that myocardial ischaemia and greater ischaemic burden 
translate into significantly worse outcome.  
 
Table 3 and online supplementary Table S1 show the risk of NFCE and all-cause mortality 
respectively in each of the three ethnic groups, adjusted for standard risk factors including 
age, gender, hypertension, diabetes mellitus, hypercholesterolemia, family history of CVD, 
smoking history, prior myocardial infarction, prior revascularization and use of lipid lowering 
or anti-hypertensive medication. Among the three ethnic groups, ischaemia on DSE was 
associated with 2 to 2.5 times the risk of NFCE and 1.2 to 1.4 times the risk for all-cause 
mortality. For each ethnic group, the risk associated with a NFCE and all-cause mortality 
increased as the burden of myocardial ischaemia increased. Importantly, peak WMSI was the 
strongest independent predictor in all-ethnic groups for both NFCE and all-cause mortality. 
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All adjusted hazard ratios for DSE parameters are significant (P<0.038), for NFCE and all-
cause mortality.  
 
Table 4 shows the C-statistic for the prediction of NFCE and all-cause mortality according to 
ethnic group, calculated on the basis of the standard risk factors alone and on the basis of the 
standard risk factors in addition to DSE parameters. The C-statistic for the prediction of 
NFCE and all-cause mortality was greater when DSE parameters were added to standard risk 
factors. These increases were statistically significant for each ethnic group indicating an 
improvement in discrimination.  
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Discussion 
 
We examined the predictive value of DSE in a multiethnic UK population. We found that 
DSE is a strong and independent predictor of NFCE and all-cause mortality irrespective of 
ethnicity. The risk of NFCE and all-cause mortality was associated with the burden of 
myocardial ischaemia, as assessed by the peak WMSI and the number of ischaemic segments 
during DSE. The addition of DSE to standard risk factor models including age, gender, 
hypertension, diabetes mellitus, hypercholesterolemia, family history of CVD, smoking 
history, prior myocardial infarction, prior revascularization and use of lipid lowering or anti-
hypertensive medication for the prediction of NFCE and all-cause mortality significantly 
increased the C statistic, an order of magnitude comparable to that observed with coronary 
calcium scoring in different ethnic populations [24, 25]. Importantly, DSE parameters 
contributed to the risk of both NFCE and all-cause mortality in three major ethnic groups 
independently of other risk factors.  
 
The prognostic value of DSE has been previously reported in large studies in patients with 
various pre-test probabilities [9, 13, 16, 26-31]. Ischaemic burden and severe wall motion 
abnormalities during stress were independently associated with events in the present study, 
findings which previous research have recognised that indicate worse prognosis [9, 13]. 
However, previous analysis has not attempted to evaluate the predictive value of DSE in 
different ethnic groups. Importantly, in all three ethnic groups studied, the addition of DSE 
parameters to clinical data improved the predictive power. This finding contrasts prior 
research, which demonstrated ethnic differences in the survival of patients undergoing 
exercise treadmill testing [8].  
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This study also demonstrated ethnicity related differences in the function, structure and 
geometry of the left ventricle at rest. Afro-Caribbean patients demonstrated greater 
concentric cardiac remodelling with significantly greater maximal LV wall thickness and LV 
mass compared to European white and Indian Asian patients. A greater LV wall thickness has 
been shown previously in Afro-Caribbean populations compared to other ethnic groups and is 
associated with an increased mortality risk [32]. Furthermore, an increased LV mass has been 
shown to be a powerful independent predictor for CVD morbidity and mortality in 
individuals previously free of clinical cardiovascular disease [33]. Treatment to control 
modifiable risk factors in Afro-Caribbean populations may reduce cardiac remodelling [34]. 
Indian Asian patients had a significantly smaller LV cavity and the smallest LV mass 
compared to Afro-Caribbean and European white patients. Other studies support these 
findings [34-36]. Indexing LV mass did not attenuate the observed difference. A decreased 
LV cavity and smaller LV mass may lead to an increase in LV wall stress and myocardial 
oxygen demand, which may increase the vulnerability to myocardial ischaemia [34]. This 
was a specific cohort of patients referred for DSE. These differences may contribute to the 
elevated CVD risk seen in Afro-Caribbean and Indian Asian ethnic groups. It is important to 
note that European white patients were significantly older than both Afro-Caribbean and 
Indian Asian patients. Therefore, for an age matched cohort the prevalence of CVD may be 
significantly different between ethnic groups.  
 
Angiographic comparisons of CAD between Caucasians and Asians have reported similar 
findings to the present study. Dhawan and Bray [37] reported no difference in the severity or 
extent of CAD between Caucasians and Asians. As shown in our study, there was a 
significant difference in age between groups, with Asians being significantly younger than 
Caucasians. In a recent study including 279,256 patients, South Asians were younger, had 
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more extensive coronary artery disease and greater prevalence of major risk factors, 
particularly diabetes compared to Caucasians [38]. However, as shown in our study, when 
correcting for these differences, outcome was similar between South Asians and Caucasians.  
Similar to our study, angiographic differences in CAD were minimal among African 
American compared to white patients, with a similar distribution of coronary vessel disease 
and mean stenosis score [39].  
 
Disproportionate rates of heart disease are seen in racial and ethnic minority populations. The 
ability to reliably risk stratify populations at greater risk of adverse cardiac events is therefore 
of great importance. Recently, cardiovascular screening demonstrated the potential to reduce 
ethnic health inequalities [40]. In our study Indian Asians had a significantly greater 
prevalence of hypertension, diabetes mellitus, and hypercholesterolemia compared to Afro-
Caribbeans and European whites. However, a significantly greater proportion of Indian 
Asians had previous coronary intervention compared to Afro-Caribbeans and European 
whites. In addition, Indian Asian and European whites had greater Canadian Cardiovascular 
Society angina classification compared to Afro-Caribbeans. Irrespective of differences in risk 
factors, the results of this study indicate that DSE adds incremental value in estimating the 
probability of cardiac events and all-cause mortality in three major ethnic groups and is 
therefore a valuable tool in the assessment of CAD. 
 
Our study has limitations. This was a prospective observational study from a single centre. 
Patients recruited into our study were referred for a clinically indicated DSE and there is the 
potential for referral bias and high pre-test probability related to a higher prevalence of co-
morbidities and symptoms. Only 18.9% on the study populations underwent coronary 
angiography within 1-month of DSE, which may bias test sensitivity and specificity. 
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Medication listed refers to treatment at time of DSE and changes in medication over the 
follow-up period were not taken into account. Due to difficulties in accurately determining 
the cause of death by reviewing death certificates or medical records, all-cause mortality was 
selected as a more objective and unbiased end point [41]. Notwithstanding these limitations, 
the present study is consistent with earlier work and extends our knowledge in different 
ethnic populations.   
 
Conclusions 
 
In a multiethnic UK cohort, DSE added incremental value to the prediction of NFCE and all-
cause mortality over that of standard CVD risk factors in Afro-Caribbean, European white 
and Indian Asian patients.  
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Figure Legends 
 
Figure 1: Study flow diagram. 
 
Figure 2: Kaplan-Meier hazard curves for the cumulative survival and freedom from non-
fatal cardiac events in each ethnic group. Kaplan-Meier hazard curves dichotomized 
according to myocardial ischaemia (A) and number of ischaemic LV segments (B).  
 
Figure 3: Kaplan-Meier hazard curves for the cumulative survival and freedom from all-
cause mortality in each ethnic group. Kaplan-Meier hazard curves dichotomized according to 
myocardial ischaemia (A) and number of ischaemic LV segments (B).  
 
 
 
